Search

Immunohematology Market

Immunohematology Market Size by Product (Reagents, Analyzers), Application (Pretransfusion Testing, Investigation of Immune Hemolysis, Perinatal Testing, Blood group Phenotyping/ Genotyping, Leucocyte and platelet Serology), Disease, End User, Region, Global Industry Analysis, Share, Growth, Trends, and Forecast 2024 to 2033

Base Year: 2023 Historical Data: 2020-22
  • Report ID: TBI-12544
  • Published Date: Aug, 2024
  • Pages: 239
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

Global immunohematology market is expected to reach USD 3.53 billion by 2033, at a CAGR of 4.2% from 2023 to 2033. Global Immunohematology market is witnessing a considerable growth owing to low operating costs, and environmental friendliness of pipeline transportation. Blood banking, also called immunohematology or transfusion medicine, is a specialized discipline within laboratory science that concentrates on blood group and antibody analysis associated with transfusions. It encompasses identifying and characterizing antigens found in red blood cell surfaces and the corresponding antibodies in plasma. The primary objective of this field involves secure and compatible transmission by matching donor blood type to recipient blood type, preventing adverse reactions. This area assumes an important role in transplantations, therapy for hematologic disorders, and managing safe practices related to transfusions overall. Immunohematologists utilize both serological techniques and molecular methods when conducting tests like crossmatching procedures for typing purposes, ensuring effective measures for safety among recipients undergoing such interventions involving donated (transfused) blood products.

Market Overview:

Immunohematology usually known as blood banking is a division of hematology which studies antigen-antibody reactions and analogous phenomena as they connect to the pathogenesis and clinical manifestations of blood disorders. A person working in this field is referred to as an immunohematologist. Their day-to-day responsibilities include blood typing, cross-matching and antibody identification. Immunohematology and Transfusion Medicine is a medical post graduate field in many countries. The specialist Immunohematology and Transfusion Physician offers expert opinion for difficult transfusions, massive transfusions, incompatibility work up, therapeutic plasmapheresis, cellular therapy, leukoreduced and washed blood products, irradiated blood therapy, stem cell procedures, platelet rich plasma therapies, HLA and cord blood banking. Other research avenues are in the arena of stem cell researches, regenerative medicine and cellular therapy. High occurrence of hematological diseases, surging number of trauma cases, increasing demand for platelets, plasma factors & immunoglobin, and increased consciousness regarding the significance of blood-transfusion related diseases & medical care are the key factors boosting the market growth. Government and private institutions are investing significantly in the development of blood banks. This would surge the demand for immunohematology devices, thereby favorably impacting market growth. Lately, rapid technological developments in immunohematology have directed the way for the development of a diagnostic approach in the direction of, in vitro study of compatibility between the donor’s and receiver’s blood. Some of the key technological advancement include automation of the immunohematology devices, developed testing devices, and new transfusion techniques. The fully automated immunohematology devices execute blood screening tests and deliver accurate results and further simplifying the identification process. Advanced antiglobulin screening instruments and assays confirm for proper blood typing. These progress have allowed clinics and hospitals to deliver emergency assistance. The companies are concentrating on improving the safety and longevity of blood stored in blood banks by updating advanced immunohematology devices. Features such as high initial investments, inadequate reimbursements of high-tech devices, and lack of awareness of technologically advanced devices in developed and developing countries hamper the market growth worldwide.

Immunohematology Market Size

Get an overview of this study by requesting a free sample

Market Dynamics:

Drivers
  • Growing awareness about the importance of blood transfusion 

Growing awareness about the importance of blood transfusion for saving the life of patients is boosting blood donation activities across the globe, which continues to play the major driver for the growth of the immunohematology market. In last few years, global events associated with blood collection, processing, testing, and storage have touched new heights. This makes a huge demand for immunohematology devices across the world, boosting growth of the immunohematology market.

  • The rise in the number of trauma cases, increasing demand for platelets, plasma factors and immunoglobin

Increase in the cases of hematological diseases, surge in the number of trauma cases, increase in demand for platelets, plasma factors and immunoglobin, and increased awareness regarding the importance of blood-transfusion related diseases & medical care are the important factors augmenting the market growth. Government and private institutions are investing significantly in the development of blood banks. This would increase the demand for immunohematology devices, thereby favorably impacting market growth.

Restraints:
  • High initial investments, inadequate reimbursements of high-tech devices

Though the clinical laboratory industry is witnessing incremental growth, reimbursement limitations of high-tech equipment, including immunohematology devices such as analyzer and reagents, are putting major restraint for market players. High cost of immunohematology devices generate needs for end-users to make high initial investments, which is limiting the sales of new immunohematology devices. As most laboratories, blood banks, and research organizations are looking for ways to reduce costs, the immunohematology market has been witnessing major restraints in its growth.

Opportunities:
  • Blood donations in developed countries

It also discovered that high-income countries, for instance the U.S. and U.K., are responsible for an over 50% share in the blood donations collected globally. This shows lucrative opportunities for immunohematology market players in developed countries. A surge in the number of blood donors, blood banks, and blood collection events in high-income countries are likely to contribute its substantial share in the growth of the immunohematology market in the upcoming years.

Segmentation Analysis:

The global Immunohematology market has been segmented based on product, application, disease, end user and regions.

  • The product segment is divided into reagents and analyzers. Reagents segment is expected for the largest market share of 63.4% in 2023. The segment is expected to register a highest CAGR during the forecast period owing to rapid technological developments and innovation of automated analyzers. The analyzers segment is expected to achieve fast-paced growth, during the forecast period. FDA clears ORTHO Sera ID-MTS for use on the ORTHO VISION Analyzer, fully automated technology from ortho clinical diagnostics aids in extended antigen phenotyping and ensures delivery of safe blood to transfusion Patients.
  • The application segment includes pretransfusion testing, investigation of immune hemolysis, perinatal testing, and blood group phenotyping / genotyping and leucocyte and platelet serology. The Investigation of immune hemolysis accounts for 28.4% of market share in 2023. Most immunohematology devices are utilized to test antigen–antibody reaction that can lead to hemolysis or RBC agglutination. Ultimately, through immunohematology tests, acquired antibodies to RBC antigens are identified, which are generated due to any kind of exposure to foreign RBCs. Leading players in the immunohematology are presenting technologically advanced immunohematology devices to progress the reliability of various tests and services performed at end-user organizations, such as laboratories and hospitals.
  • The disease segment includes blood-related diseases, HIV and hepatitis. The HIV segment accounted for the largest share of the market in 2023 which is 38.3%. Immunohematology is commonly known as blood banking, which deals with preparation of blood components for transfusion. It aids in reduction of transfusion-related fatalities, such as HIV and thalassemia.
  • The end user segment includes hospitals, blood banks and diagnostic laboratories. The hospital segment is expected to have the highest market share of around 39.21% during the forecasting period. Blood banks segment is expected to register the highest CAGR in the forecasting period. Vital importance of immunohematology devices in hospitals for screening the donor’s blood for any infections and also for its compatibility with the receiver’s blood is a key factor leading to increasing demand from hospitals.
Regional segmentation analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and the Middle East and Africa. North America is the leading region in the global Immunohematology market, accounting for around 35.2% of the market share in 2023.

North America Immunohematology Market Share in 2023 - 35.2%

 

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

  • North America is the leading regional segment in terms of revenue generation. Acceptance of advanced technology as well as preference for automated devices are boosting the market growth in the region. Furthermore, U.S FDA gives clearance to many innovation products which encourages the companies to invest more in R&D.
  • Europe is the second largest region in terms of revenue generation with a share of 29.2% followed by APAC region. APAC region is predicted to be the fastest growing region during the forecast period owing to the gradual adoption of advanced treatment options, increased healthcare spending and availability of superior treatment facilities at lower prices in countries such as India & China.
Competitive Analysis:

Developing and developed countries are offering greater opportunities and major players are continuously focused on new developments, strategic partnerships, acquisitions and venture capital investments to obtain high growth in the market.

For instance, FDA clears ORTHO Sera ID-MTS for use on the ORTHO VISION Analyzer, fully automated technology from ortho clinical diagnostics aids in extended antigen phenotyping and ensures delivery of safe blood to transfusion Patients.

In April 2018, Immucor announced FDA clearance in the United States to best match donor-patient blood for Echo LumenaTM. This is designed for the small to mid-volume laboratory segment, is Immucor’s fifth generation immunohematology instrument and gets brilliant performance and clearer test results with the smallest benchtop footprint and the fastest type and screen turnaround time on the global market.

List of Key Market Players:
  • Siemens Healthcare GmbH
  • Bio-Rad Laboratories
  • Ortho Clinical Diagnostics
  • Grifols
  • Immucor
  • Abbott laboratories
  • Beckman Coulter
  • ThermoFisher
  • Becton Dickinson
  • Merck KGaA
Key Target Audience
  • Hospitals
  • Blood Banks
  • Government Authorities
  • Diagnostic laboratories

Report Description:

  • The base year for the study has been considered 2023, historic years are 2020, 2021 and 2022 and, the forecast period considered is from 2024 to 2033. The global Immunohematology market is analyzed on the basis of value (USD billion).
  • The study delivers a comprehensive analysis of global Immunohematology market by product, application, disease, end user and regions. The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2024 to 2023.
  • Porter’s Five Forces model is used in order to recognize the competitive scenario in the global Immunohematology market. This report incorporates the industry analysis which is focused on providing an extensive view of the Immunohematology market.
  • The study also includes attractiveness analysis of product, application, disease, end user and regions which are bench-marked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
  • The report provides company profile of the key players operating in the Immunohematology market and a comparative analysis based on their business overviews, product offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
  • The market estimates have been evaluated by considering the effect of different political, economic, social, technological and legal factors which are based on our extensive secondary research, primary research, and in-house databases.

Frequesntly Asked Questions

As per The Brainy Insights, the size of the immunohematology market was valued at USD 2.44 billion in 2023 and is anticipated to reach USD 3.53 billion by 2033.

Global immunohematology market is growing at a CAGR of 4.2% during the forecast period 2024-2033.

The North America region emerged as the largest market for the immunohematology.

Growing awareness about the importance of blood transfusion is the key driving factor for the immunohematology market.

High initial investments, inadequate reimbursements of high-tech devices could hamper the market growth.

Blood donations in developed countries industries will provide huge opportunities to the market.

Key players are Siemens Healthcare GmbH, Bio-Rad Laboratories, Ortho Clinical Diagnostics, Grifols, Immucor, Abbott laboratories.

Get Your Report Customized

  • Further segmentation of the market on the basis of type, application, end use, product, technology, method, process and any other segment depending on the market
  • Segmentation on the basis of any specific country or region
  • Any segment can be classified on the basis of application
  • Application segment can be further divided on the basis of companies
  • The companies profiled are not limited, we can incorporate additional companies of your choice
  • We can split the company market share on the basis of product, application and region
  • Report can be prepared for any specific country/region/segment
  • Customers can be added on the basis of regions and countries
Request for Customization

1. Introduction
    1.1. Objectives of the Study
    1.2. Market Definition
    1.3. Research Scope
    1.4. Currency
    1.5. Key Target Audience

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
    4.1. Porter’s Five Forces Analysis
    4.2. Value Chain Analysis
    4.3. Top Investment Pockets
          4.3.1. Market Attractiveness Analysis By Product
          4.3.2. Market Attractiveness Analysis By Application
          4.3.3. Market Attractiveness Analysis By Disease
          4.3.4. Market Attractiveness Analysis By End-User
          4.3.5. Market Attractiveness Analysis By Region
    4.4. Industry Trends

5. Market Dynamics
    5.1. Market Evaluation
    5.2. Drivers
          5.2.1. Growing awareness about the importance of blood transfusion
          5.2.2. The rise in the number of trauma cases, increasing demand for platelets, plasma factors and immunoglobin
    5.3. Restrains
          5.3.1. High initial investments, inadequate reimbursements of high-tech devices
    5.4. Opportunities
          5.4.1. Blood donations in developed countries

6. Global Immunohematology Market Analysis and Forecast, By Product
    6.1. Segment Overview
    6.2. Reagents
    6.3. Analyzers

7. Global Immunohematology Market Analysis and Forecast, By Application
    7.1. Segment Overview
    7.2. Pretransfusion testing
          7.2.1. ABO and Rh Typing
          7.2.2. Antibody Detection
          7.2.3. Cross matching
    7.3. Investigation of immune hemolysis
    7.4. Perinatal testing
    7.5. Blood group Phenotyping / genotyping
    7.6. Leucocyte and platelet Serology

8. Global Immunohematology Market Analysis and Forecast, By Disease
    8.1. Segment Overview
    8.2. Blood-related diseases
    8.3. HIV
    8.4. Hepatitis

9. Global Immunohematology Market Analysis and Forecast, By End-User
    9.1. Segment Overview
    9.2. Hospitals
    9.3. Blood banks
    9.4. Diagnostic laboratories

10. Global Immunohematology Market Analysis and Forecast, By Regional Analysis
    10.1. Segment Overview
    10.2. North America
          10.2.1. U.S.
          10.2.2. Canada
          10.2.3. Mexico
    10.3. Europe
          10.3.1. Germany
          10.3.2. France
          10.3.3. U.K.
          10.3.4. Italy
          10.3.5. Spain
    10.4. Asia-Pacific
          10.4.1. Japan
          10.4.2. China
          10.4.3. India
    10.5. South America
          10.5.1. Brazil
    10.6. Middle East and Africa
          10.6.1. UAE
          10.6.2. South Africa

11. Global Immunohematology Market-Competitive Landscape
    11.1. Overview
    11.2. Market Share of Key Players in Global Immunohematology Market
          11.2.1. Global Company Market Share
          11.2.2. North America Company Market Share
          11.2.3. Europe Company Market Share
          11.2.4. APAC Company Market Share
    11.3. Competitive Situations and Trends
          11.3.1. Product Launches and Developments
          11.3.2. Partnerships, Collaborations, and Agreements
          11.3.3. Mergers & Acquisitions
          11.3.4. Expansions

12. Company Profiles
    12.1. Siemens Healthcare GmbH
          12.1.1. Business Overview
          12.1.2. Company Snapshot
          12.1.3. Company Market Share Analysis
          12.1.4. Company Product Portfolio
          12.1.5. Recent Developments
          12.1.6. SWOT Analysis
    12.2. Bio-Rad Laboratories
          12.2.1. Business Overview
          12.2.2. Company Snapshot
          12.2.3. Company Market Share Analysis
          12.2.4. Company Product Portfolio
          12.2.5. Recent Developments
          12.2.6. SWOT Analysis
    12.3. Ortho Clinical Diagnostics
          12.3.1. Business Overview
          12.3.2. Company Snapshot
          12.3.3. Company Market Share Analysis
          12.3.4. Company Product Portfolio
          12.3.5. Recent Developments
          12.3.6. SWOT Analysis
    12.4. Grifols
          12.4.1. Business Overview
          12.4.2. Company Snapshot
          12.4.3. Company Market Share Analysis
          12.4.4. Company Product Portfolio
          12.4.5. Recent Developments
          12.4.6. SWOT Analysis
    12.5. Immucor
          12.5.1. Business Overview
          12.5.2. Company Snapshot
          12.5.3. Company Market Share Analysis
          12.5.4. Company Product Portfolio
          12.5.5. Recent Developments
          12.5.6. SWOT Analysis
    12.6. Abbott laboratories
          12.6.1. Business Overview
          12.6.2. Company Snapshot
          12.6.3. Company Market Share Analysis
          12.6.4. Company Product Portfolio
          12.6.5. Recent Developments
          12.6.6. SWOT Analysis
    12.7. Beckman Coulter
          12.7.1. Business Overview
          12.7.2. Company Snapshot
          12.7.3. Company Market Share Analysis
          12.7.4. Company Product Portfolio
          12.7.5. Recent Developments
          12.7.6. SWOT Analysis
    12.8. ThermoFisher
          12.8.1. Business Overview
          12.8.2. Company Snapshot
          12.8.3. Company Market Share Analysis
          12.8.4. Company Product Portfolio
          12.8.5. Recent Developments
          12.8.6. SWOT Analysis
    12.9. Becton Dickinson
          12.9.1. Business Overview
          12.9.2. Company Snapshot
          12.9.3. Company Market Share Analysis
          12.9.4. Company Product Portfolio
          12.9.5. Recent Developments
          12.9.6. SWOT Analysis
    12.10. Merck KGaA
          12.10.1. Business Overview
          12.10.2. Company Snapshot
          12.10.3. Company Market Share Analysis
          12.10.4. Company Product Portfolio
          12.10.5. Recent Developments
          12.10.6. SWOT Analysis

List of Table

1. Global Immunohematology Market, By Product, 2020-2033 (USD Billion)

2. Global Reagents Immunohematology  Market, By Region, 2020-2033 (USD Billion)

3. Global Analyzers Immunohematology  Market, By Region, 2020-2033 (USD Billion)

4. Global Immunohematology Market, By Application, 2020-2033 (USD Billion)

5. Global Pretransfusion testing Immunohematology Market, By Region, 2020-2033 (USD Billion)

6. Global Investigation of immune hemolysis Immunohematology Market, By Region, 2020-2033 (USD Billion)

7. Global Perinatal testing Immunohematology Market, By Region, 2020-2033 (USD Billion)

8. Global Blood group Phenotyping / genotyping Immunohematology Market, By Region, 2020-2033 (USD Billion)

9. Global Leucocyte and platelet Serology, Perinatal testing Immunohematology Market, By Region, 2020-2033 (USD Billion)

10. Global Immunohematology Market, By Disease, 2020-2033 (USD Billion)

11. Global Blood-related diseases Immunohematology Market, By Region, 2020-2033 (USD Billion)

12. Global HIV Immunohematology Market, By Region, 2020-2033 (USD Billion)

13. Global Hepatitis Immunohematology Market, By Region, 2020-2033 (USD Billion)

14. Global Immunohematology Market, By End-User, 2020-2033 (USD Billion)

15. Global Hospitals Immunohematology Market, By Region, 2020-2033 (USD Billion)

16. Global Blood banks Immunohematology Market, By Region, 2020-2033 (USD Billion)

17. Global Diagnostic laboratories Immunohematology Market, By Region, 2020-2033 (USD Billion)

18. Global Immunohematology Market, By Region, 2020-2033 (USD Billion) 

19. Global Immunohematology Market, By North America, 2020-2033 (USD Billion)

20. North America Immunohematology Market, By Product, 2020-2033 (USD Billion)

21. North America Immunohematology Market, By Application, 2020-2033 (USD Billion)

22. North America Immunohematology Market, By Disease, 2020-2033 (USD Billion)

23. North America Immunohematology Market, By End-User, 2020-2033 (USD Billion)

24. U.S. Immunohematology Market, By Product, 2020-2033 (USD Billion)

25. U.S. Immunohematology Market, By Application, 2020-2033 (USD Billion)

26. U.S. Immunohematology Market, By Disease, 2020-2033 (USD Billion)

27. U.S. Immunohematology Market, By End-User, 2020-2033 (USD Billion)

28. Canada Immunohematology Market, By Product, 2020-2033 (USD Billion)

29. Canada Immunohematology Market, By Application, 2020-2033 (USD Billion)

30. Canada Immunohematology Market, By Disease, 2020-2033 (USD Billion)

31. Canada Immunohematology Market, By End-User, 2020-2033 (USD Billion)

32. Mexico Immunohematology Market, By Product, 2020-2033 (USD Billion)

33. Mexico Immunohematology Market, By Application, 2020-2033 (USD Billion)

34. Mexico Immunohematology Market, By Disease, 2020-2033 (USD Billion)

35. Mexico Immunohematology Market, By End-User, 2020-2033 (USD Billion)

36. Europe Immunohematology Market, By Product, 2020-2033 (USD Billion)

37. Europe Immunohematology Market, By Application, 2020-2033 (USD Billion)

38. Europe Immunohematology Market, By Disease, 2020-2033 (USD Billion)

39. Europe Immunohematology Market, By End-User, 2020-2033 (USD Billion)

40. Germany Immunohematology Market, By Product, 2020-2033 (USD Billion)

41. Germany Immunohematology Market, By Application, 2020-2033 (USD Billion)

42. Germany Immunohematology Market, By Disease, 2020-2033 (USD Billion)

43. Germany Immunohematology Market, By End-User, 2020-2033 (USD Billion)

44. France Immunohematology Market, By Product, 2020-2033 (USD Billion)

45. France Immunohematology Market, By Application, 2020-2033 (USD Billion)

46. France Immunohematology Market, By Disease, 2020-2033 (USD Billion)

47. France Immunohematology Market, By End-User, 2020-2033 (USD Billion)

48. U.K. Immunohematology Market, By Product, 2020-2033 (USD Billion)

49. U.K. Immunohematology Market, By Application, 2020-2033 (USD Billion)

50. U.K. Immunohematology Market, By Disease, 2020-2033 (USD Billion)

51. U.K. Immunohematology Market, By End-User, 2020-2033 (USD Billion)

52. Italy Immunohematology Market, By Product, 2020-2033 (USD Billion)

53. Italy Immunohematology Market, By Application, 2020-2033 (USD Billion)

54. Italy Immunohematology Market, By Disease, 2020-2033 (USD Billion)

55. Italy Immunohematology Market, By End-User, 2020-2033 (USD Billion)

56. Spain Immunohematology Market, By Product, 2020-2033 (USD Billion)

57. Spain Immunohematology Market, By Application, 2020-2033 (USD Billion)

58. Spain Immunohematology Market, By Disease, 2020-2033 (USD Billion)

59. Spain Immunohematology Market, By End-User, 2020-2033 (USD Billion)

60. Asia Pacific Immunohematology Market, By Product, 2020-2033 (USD Billion)

61. Asia Pacific Immunohematology Market, By Application, 2020-2033 (USD Billion)

62. Asia Pacific Immunohematology Market, By Disease, 2020-2033 (USD Billion)

63. Asia Pacific Immunohematology Market, By End-User, 2020-2033 (USD Billion)

64. Japan Immunohematology Market, By Product, 2020-2033 (USD Billion)

65. Japan Immunohematology Market, By Application, 2020-2033 (USD Billion)

66. Japan Immunohematology Market, By Disease, 2020-2033 (USD Billion)

67. Japan Immunohematology Market, By End-User, 2020-2033 (USD Billion)

68. China Immunohematology Market, By Product, 2020-2033 (USD Billion)

69. China Immunohematology Market, By Application, 2020-2033 (USD Billion)

70. China Immunohematology Market, By Disease, 2020-2033 (USD Billion)

71. China Immunohematology Market, By End-User, 2020-2033 (USD Billion)

72. India Immunohematology Market, By Product, 2020-2033 (USD Billion)

73. India Immunohematology Market, By Application, 2020-2033 (USD Billion)

74. India Immunohematology Market, By Disease, 2020-2033 (USD Billion)

75. India Immunohematology Market, By End-User, 2020-2033 (USD Billion)

76. South America Immunohematology Market, By Product, 2020-2033 (USD Billion)

77. South America Immunohematology Market, By Application, 2020-2033 (USD Billion)

78. South America Immunohematology Market, By Disease, 2020-2033 (USD Billion)

79. South America Immunohematology Market, By End-User, 2020-2033 (USD Billion)

80. Brazil Immunohematology Market, By Product, 2020-2033 (USD Billion)

81. Brazil Immunohematology Market, By Application, 2020-2033 (USD Billion)

82. Brazil Immunohematology Market, By Disease, 2020-2033 (USD Billion)

83. Brazil Immunohematology Market, By End-User, 2020-2033 (USD Billion)

84. Middle East and Africa Immunohematology Market, By Product, 2020-2033 (USD Billion)

85. Middle East and Africa Immunohematology Market, By Application, 2020-2033 (USD Billion)

86. Middle East and Africa Immunohematology Market, By Disease, 2020-2033 (USD Billion)

87. Middle East and Africa Immunohematology Market, By End-User, 2020-2033 (USD Billion)

88. UAE Immunohematology Market, By Product, 2020-2033 (USD Billion)

89. UAE Immunohematology Market, By Application, 2020-2033 (USD Billion)

90. UAE Immunohematology Market, By Disease, 2020-2033 (USD Billion)

91. UAE Immunohematology Market, By End-User, 2020-2033 (USD Billion)

92. South Africa Immunohematology Market, By Product, 2020-2033 (USD Billion)

93. South Africa Immunohematology Market, By Application, 2020-2033 (USD Billion)

94. South Africa Immunohematology Market, By Disease, 2020-2033 (USD Billion)

95. South Africa Immunohematology Market, By End-User, 2020-2033 (USD Billion)

List of Figures 

1. Global Immunohematology Market Segmentation

2. Immunohematology Market: Research Methodology

3. Market Size Estimation Methodology: Bottom-Up Approach

4. Market Size Estimation Methodology: Top-Down Approach

5. Data Triangulation

6. Porter’s Five Forces Analysis 

7. Value Chain Analysis 

8. Global Immunohematology Market Attractiveness Analysis By Product

9. Global Immunohematology Market Attractiveness Analysis By Application

10. Global Immunohematology Market Attractiveness Analysis By Disease

11. Global Immunohematology Market Attractiveness Analysis By End-User

12. Global Immunohematology Market Attractiveness Analysis By Region

13. Global Immunohematology Market: Dynamics

14. Global Immunohematology Market Share by Product (2023 & 2033)

15. Global Immunohematology Market Share by Application (2023 & 2033)

16. Global Immunohematology Market Share by Disease (2023 & 2033)

17. Global Immunohematology Market Share by End-User (2023 & 2033)

18. Global Immunohematology Market Share by Regions (2023 & 2033)

19. Global Immunohematology Market Share by Company (2023)

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. The Brainy Insights has segmented the global Immunohematology market on the basis of below mentioned segments:

Global Immunohematology Market by Product:

  • Reagents
  • Analyzers

Global Immunohematology Market by Application:

  • Pretransfusion testing
    •   ABO and Rh Typing
    •   Antibody Detection
    •   Cross matching
  • Investigation of immune hemolysis
  • Perinatal testing
  • Blood group Phenotyping / genotyping
  • Leucocyte and platelet Serology

Global Immunohematology Market by Disease:

  • Blood-related diseases
  • HIV
  • Hepatitis

Global Immunohematology Market by End User:

  • Hospitals
  • Blood banks
  • Diagnostic laboratories

Global Immunohematology Market by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa  
    • UAE
    • South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Ask for customization Request Sample Speak to analyst Inquire before buying

Flexible Purchase Options

  • Chapters of your choice
  • Quantitative Information for Historical & Forecasted Data
  • Regional/Country Level Reports
Request for Special Pricing

Get in touch with us

+1-315-215-1633

sales@thebrainyinsights.com

Our Clients

Why choose us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date